| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | CA2197185A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 02/22/1996 | CA2197172A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | CA2196982A1 Anti-acne cosmetic compositions |
| 02/22/1996 | CA2196756A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 02/22/1996 | CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain |
| 02/22/1996 | CA2195972A1 Morpholine derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2195782A1 Composition and method for treating anxiety |
| 02/22/1996 | CA2195779A1 Composition and method for protection against drug dependency |
| 02/22/1996 | CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors |
| 02/21/1996 | EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists |
| 02/21/1996 | EP0697403A1 Derivatives of glycinamides as cholecystokinin receptor agonists |
| 02/21/1996 | EP0697011A1 Large potassium bicarbonate crystals and process for the preparation thereof |
| 02/21/1996 | EP0588797B1 N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | EP0479903B1 Substituted imidazoles useful as angiotensin ii blockers |
| 02/21/1996 | CN1117295A Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 02/21/1996 | CN1117292A Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/21/1996 | CN1117291A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl|B¨pyran-2-ones useful to treat retroviral infections |
| 02/21/1996 | CN1117045A Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
| 02/21/1996 | CN1116929A Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended caments prevention or treatment of symptoms associated with the syndrome of spontaneous or prec..... |
| 02/21/1996 | CN1116924A Utilisation des acides sulfoniques comme agents antivieillissement dans une composition cosmetiqueou dermatologique |
| 02/21/1996 | CN1031060C Process for preparing esters |
| 02/21/1996 | CN1031059C Method for preparation of 7-oxa-bi-eycloheptyl substituted heterocyclic amide prostaglandin analogs |
| 02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5492927 Non-peptide tachykinin receptor antagonists to treat allergy |
| 02/20/1996 | US5492923 Drug for treating arterial hypertension and atherosclerosis |
| 02/20/1996 | US5492921 Preventing restenosis |
| 02/20/1996 | US5492919 Irritable bowel disorder |
| 02/20/1996 | US5492915 Substituted quinolyl compounds exhibiting selective leukotriene B4 antagonist activity |
| 02/20/1996 | US5492914 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof |
| 02/20/1996 | US5492713 Nutriment preparation |
| 02/20/1996 | CA2156579A1 Method of treating vascular leak syndrome |
| 02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
| 02/15/1996 | WO1996004395A1 Recombinant virus vectors |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004299A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004287A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/15/1996 | WO1996004281A1 Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines |
| 02/15/1996 | WO1996004277A1 Pyrrolinone-based peptidomimetics |
| 02/15/1996 | WO1996004276A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004275A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004274A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | WO1996004272A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004266A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996004245A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 02/15/1996 | WO1996004233A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | WO1996003999A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | CA2632452A1 Substituted o6-benzylguanines and use thereof |
| 02/15/1996 | CA2196809A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2196700A1 N-substituted azabicycloheptane derivatives, the preparation aand use thereof |
| 02/15/1996 | CA2196608A1 Pyrrolinone-based peptidomimetics |
| 02/15/1996 | CA2196219A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196218A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196193A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | CA2196168A1 Recombinant virus vectors |
| 02/15/1996 | CA2196102A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2195850A1 Substituted indoles |
| 02/15/1996 | CA2195107A1 Azetidine, pyrrolidine and piperidine derivatives |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2172986A1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 02/14/1996 | EP0696594A1 Human interleukin 6 inhibitor |
| 02/14/1996 | EP0696593A2 Inhibitors of farnesyl protein transferase |
| 02/14/1996 | EP0696583A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 02/14/1996 | EP0696281A1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 02/14/1996 | EP0696276A1 N-acyl substituted phenyl piperidines as bronchodilators and anti-inflammatory agents |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | EP0696272A1 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives |
| 02/14/1996 | EP0696271A1 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives |
| 02/14/1996 | EP0696270A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs |
| 02/14/1996 | EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/14/1996 | CN1116627A New peptides derived from trifluorumethylketones, process for their preparation and the pharmaceutical compositions which contain them |
| 02/14/1996 | CN1116626A Glucopyranoside benzothiophens |
| 02/13/1996 | US5491242 Treating diabetes mellitus |
| 02/13/1996 | US5491166 Inhibitors of HIV protease useful for the treatment of AIDS |
| 02/13/1996 | US5491164 Inhibitors of farnesyl-protein transferase |
| 02/13/1996 | US5491163 (Thia)cycloalkyl[B]indoles |
| 02/13/1996 | US5491150 Supplementary therpeutic agents for the treatment of immunodeficiency syndrome |
| 02/13/1996 | US5491147 Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment |
| 02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
| 02/13/1996 | US5491130 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 02/13/1996 | US5490498 Adding fluorocarbon along with breathing gas which oxygenates the fluorocarbon; treatment of respiratory distress syndrome |
| 02/12/1996 | CA2155448A1 Inhibitors of farnesyl protein transferase |
| 02/12/1996 | CA2154977A1 Benzimidazolesulfonamide derivatives and pharmaceutical composition |
| 02/11/1996 | CA2155629A1 Human interleukin 6 inhibitor |